Reversal of glucocorticoid-induced skin atrophy

Details Reversal of glucocorticoid-induced skin atrophy Reversal of glucocorticoid-induced skin atrophy

1989-08-31

1991-05-28

Friedman, Stanley J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

514180, 514381, 514438, 514532, 514559, 514569, 514570, 514617, 514725, 514732, 514928, A61K 3107, A61K 3156

Patent

active

050195697

ABSTRACT:
The present invention is directed to the topical administration of a retinoid-containing pharmaceutical composition for reversing the effects of glucocorticoid-induced skin atrophy.

REFERENCES:
patent: 3729568 (1973-04-01), Kligman
patent: 4126693 (1978-11-01), Cander et al.
patent: 4487782 (1989-12-01), Mezick
patent: 4889847 (1989-12-01), Kligman et al.

Affiliated with

Also associated with

Rating

Reversal of glucocorticoid-induced skin atrophy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Reversal of glucocorticoid-induced skin atrophy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reversal of glucocorticoid-induced skin atrophy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-36180